Population exposure-response model to support dosing evaluation of ixekizumab in patients with chronic plaque psoriasis.

Item

http://www.wikidata.org/entity/Q51092732

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh-hant

name

Population exposure-response m ...... with chronic plaque psoriasis.

@en

Population exposure-response m ...... with chronic plaque psoriasis.

@nl

type

Item

label

Population exposure-response m ...... with chronic plaque psoriasis.

@en

Population exposure-response m ...... with chronic plaque psoriasis.

@nl

prefLabel

Population exposure-response m ...... with chronic plaque psoriasis.

@en

Population exposure-response m ...... with chronic plaque psoriasis.

@nl

P1476

Population exposure-response m ...... with chronic plaque psoriasis.

@en

P2093

Cheng-Cai Tang

http://www.w3.org/2001/XMLSchema#string

Gregory S Cameron

http://www.w3.org/2001/XMLSchema#string

Julie H Satterwhite

http://www.w3.org/2001/XMLSchema#string

Lai-San Tham

http://www.w3.org/2001/XMLSchema#string

Siak-Leng Choi

http://www.w3.org/2001/XMLSchema#string

Subhashis Banerjee

http://www.w3.org/2001/XMLSchema#string

P2860

Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: a randomised trial

Current and future management of psoriasis

Informative dropout modeling of longitudinal ordered categorical data and model validation: application to exposure-response modeling of physician's global assessment score for ustekinumab in patients with psoriasis.

Novel therapies for psoriasis.

Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics.

Serum levels of TNF-alpha, IFN-gamma, IL-6, IL-8, IL-12, IL-17, and IL-18 in patients with active psoriasis and correlation with disease severity

Efficacy of biologics in the treatment of moderate to severe psoriasis: a network meta-analysis of randomized controlled trials.

Placebo response in relation to clinical trial design: a systematic review and meta-analysis of randomized controlled trials for determining biologic efficacy in psoriasis treatment.

Population-based exposure-efficacy modeling of ustekinumab in patients with moderate to severe plaque psoriasis.

Treatment of psoriasis.

P304

1117-1124

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JCPH.312

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-04-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24752880

http://www.w3.org/2001/XMLSchema#string